Determination of Antibody Titration between Clinical and Community-Based Patients for O, H, AH and BH Antigens in Salmonella Samples by Wani, Nisar Ahmad et al.
Wani et al                                                                                                                  Journal of Drug Delivery & Therapeutics. 2019; 9(3):194-199 
ISSN: 2250-1177                                                                                  [194]                                                                                 CODEN (USA): JDDTAO 
Available online on 15.05.2019 at http://jddtonline.info 
Journal of Drug Delivery and Therapeutics 
Open Access to Pharmaceutical and Medical Research 
© 2011-18, publisher and licensee JDDT, This is an Open Access article which permits unrestricted 
non-commercial use, provided the original work is properly cited 
Open  Access                                                                                                                                                     Research Article 
Determination of Antibody Titration between Clinical and Community-
Based Patients for O, H, AH and BH Antigens in Salmonella Samples  
Nisar Ahmad Wani 1, Jaianand Kannaiyan2, Balaji Paulraj2, Veeramanikandan Veeramani1* 
1PG & Research Centre in Microbiology, MGR College, Dr. MGR Nagar, Hosur, Tamil Nadu, India 
2PG & Research Centre in Biotechnology, MGR College, Dr. MGR Nagar, Hosur, Tamil Nadu, India 
 
ABSTRACT 
The aim of the study is to determine the baseline antibody titer of Salmonella bacteria in different positive samples with a view to establishing 
the significant titer for Widal agglutination test in Kashmir. The Widal test was performed on each serum. The slide agglutin ation test was first 
done and then positive samples were further subjected to tube agglutination for quantitative titration. The most commonly utilized diagnostic 
test for enteric fever is a Widal test, which detects agglutinating antibodies against the O, H, AH and BH antigens of S. typhi. The results of the 
Widal test showed that out of 413 samples 219 were positive for Antigen O, 165 were positive for Antigen H, 17 were positive for Anti gen AH 
and 12 were positive for Antigen BH. The highest percentage cases were with Antigen-O whereas the lowest percentage was found in Antigen-
BH. The difference between clinical and community-based patients have been studied.  
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INTRODUCTION 
The S. typhi genomics work published in 2015 has shown the 
spread of the H58 lineage into Africa from Asia, predicting 
that antimicrobial resistance is a problem that is likely to 
increase over time1. The work presented in this supplement 
should raise the awareness of typhoid fever in rural locations 
in Africa and follow-up studies should be conducted in other 
rural settings that were not sampled through TSAP. 
However, further studies on typhoid fever are confounded by 
the available diagnostic testing methods2. The ongoing 
investments by the Bill and Melinda Gates Foundation and 
other donors will hopefully yield better diagnostic tests that 
can be used at the point of care without the need for 
cumbersome and insensitive blood culture methods3. The 
TSAP study results show a great need for these vaccines and 
hopefully provide further impetus to move the agenda to 
make these vaccines available to the populations in the 
greatest need. The possible future vaccination strategies in 
Africa include pre-emptive, responsive (in the case of an 
outbreak) and food handler immunization4. 
Typhoid fever is still a deadly disease in developing 
countries, particularly in India. Although, the pediatric 
population is most affected by this disease, yet the disease is 
an important cause of morbidity and mortality in adult 
populations also. There are 16 million annual cases of 
typhoid fever, 1.3 billion cases of gastroenteritis and 3 
million deaths worldwide due to Salmonella5. In brief, 
Salmonella is facultative anaerobe, gram-negative flagellated 
rod-shaped bacterium which is about 2-3 x 0.4-0.6 µm in size 
6,7.  It is among the most commonly isolated foodborne 
pathogens associated with fresh fruits and vegetables. 
The disease typhoid fever is an orally transmitted infectious 
disease caused by the bacteria S. typhi. It is usually caused by 
consuming contaminated water and food. As S. typhi bacteria 
can survive in water for days, contamination of surface water 
such as sewage, freshwater and groundwater act as a major 
etiological agent of typhoid. Defecation in open places is 
another notable cause of typhoid transmission. Unpacked 
food, cut fruits kept uncovered for some time are an 
important cause of contamination in most developing 
countries. The papaya has a neutral pH and its cut surface 
can support the growth of various microorganisms. 
Inhabiting in a congested locality or household is 
significantly related with typhoid fever8. Again, the habit of 
washing vegetables and compulsory use of sanitary latrine 
for defecation have been found to prevent typhoid9.  
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Typhoid fever continues to be a global health problem, with 
an estimated 12 to 33 million cases occurring worldwide 
each year. Incidence of typhoid fever has been estimated at 
approximately 17 million cases with 6,00,000 associated 
deaths occurring annually10. Typhoid fever was so called 
because it resembled typhus. The first detailed description of 
typhoid was given by William Jenner in 1850. The term 
enteric fever was introduced in 1869. The S. typhi was 
discovered by Eberth in 1880 and was first cultured by Gafiy 
188411. The prevalence of typhoid fever is increasing 
tremendously in Kashmir region because of poor sanitation, 
contaminated food, and water, lack of medical awareness 
and unhygienic education. The aim of this study is to find out 
the prevalence of typhoid fever in the Kashmir valley. The 
samples were carried out from different categories of 
patients, Including males, females, and children with the age 
group between 5 to 80 years and were examined in a 
laboratory using various tests. 
MATERIALS AND METHODS 
Collection, processing of samples 
The samples obtained from males, females, and children with 
the age group between 5 to 80 years were collected for 
epidemiological investigations in Kashmir province state of 
Jammu and Kashmir- India. The total sample size of 676 was 
collected from various hospitals, clinical laboratories, and 
communities. 
Identification 
The standard Gram Staining, Slide test, and Tube test were 
performed for identification of Salmonella as per standard 
methodology. 
Widal test 
The Widal tube agglutination test was done on all sera 
collected from different laboratory diagnosis methods using 
commercially available antigens (Tulip diagnostics, India). 
0.4ml of two-fold serially diluted patient’s sera (1:20 to 
1:1280) in 0.9% normal saline were tested by adding an 
equal volume of antigen. A negative control was included in 
each batch of the test. The tubes were incubated at 37ºC for 
24 h and then examined for agglutination12and higher for 
anti TH antibodies were taken as a cut of value to indicate a 
recent infection of typhoid fever. 
RESULT AND DISCUSSION 
Widal Baseline titre 
The laboratory diagnosis of typhoid fever depends upon 
either the isolates of S. typhi or the detection of titers of 
agglutinating serum antibodies against the anti - O, anti - H, 
anti-AH and anti BH of S. typhi.  The titer value of S. typhi - O 
for the two groups, includes patients group table 1 and 
community control group table 2 shows the serum titer 
values. The titer value of S. typhi H for the two groups 
includes patient group table 3 and community control group 
table 4 shows the serum titer values. The titer value of S. 
typhi AH for the two groups includes patient group table 5 
and community control group table 6 shows the serum titer 
values. The titer value of S. typhi BH for the two groups 
includes patient group table 7 and community control group 
table 8 shows the serum titer values.  
 
Table 1.  Serum titre value among patients against O 
S. 
N
o. 
Age Group (in 
years) 
Serum titre (n = 400) 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 
1 <1 to 10 (33) 6 9 7 10 1 -- -- 
2 11 to 20 (40) 7 8 12 11 2 -- -- 
3 21 to 30 (52) 2 3 31 13 3 -- -- 
4 31 to 40 (146) 3 5 94 30 9 5 -- 
5 41 to 50 (115) 1 3 82 20 6 3 -- 
6 51 to 60 (10) 2 1 5 1 1 -- -- 
7 61 to 70 (03) 1 2 -- -- -- -- -- 
8 71 to 80 (01) -- -- 1 -- -- -- -- 
9 > 80 (-) -- -- -- -- -- --- -- 
Total (n = 400) 22(5.5) 31(7.75) 232(58) 85(21.25) 22(5.5) 8(2)  
 
Table 1 shows that the age group of <1 to 10 the highest 
number of samples i.e., 10 out of 33 gives a titer value of 
1:80. And in the age group of 11 to 20 the highest number of 
samples i.e., 12 out of 40 gives a titer value of 1:40, in the age 
group of 21 to 30 the highest number of samples i.e., 31 out 
of 52 gives a titre value of 1:40, in the age group of 31 to 40 
the highest number of samples i.e., 94 out of 146 gives a titer 
value of 1:40, in the age group of 41 to 50 the highest 
number of samples i.e., 82 out of 115 gives a titer value of 
1:40, in the age group of 51 to 60 the highest number of 
samples i.e., 5 out of 10 gives a titer value of 1:40, in the age 
group of 61 to 70 the highest number of samples i.e., 2 out of 
3 gives a titer value of 1:20 and in the age group of 71 to 80 
the highest number of samples i.e., 1 out of 1 gives a titer 
value of 1:40 . The highest number of cases falls on the serum 
titer of 1:40 (232 cases), followed by 1:80 (85), 1:20 (31), 
1:10 (22), 1:160 (22) and 1:320 (8). 
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Table 2. Serum titer value among Community controls against O 
S. 
No. 
Age Group 
(in years) 
Serum titre (n = 400) 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 
1 <1 to 10 (20) 2 5 11 2 -- -- -- 
2 11 to 20 (27) 4 8 6 9 -- -- -- 
3 21 to 30 (45) 3 4 15 19 2 2 -- 
4 31 to 40 (135) 6 12 46 62 8 1 -- 
5 41 to 50 (110) 1 9 43 51 4 2 -- 
6 51 to 60 (59) 5 6 38 8 2 -- -- 
7 61 to 70 (02) 1 1 -- -- -- -- -- 
8 71 to 80 (01) 1 -- -- -- -- -- -- 
9 > 80 (01) -- -- -- 1 -- --- -- 
Total(n = 400) % 23(5.75) 45(11.25) 159(39.75) 152(38) 16(4) 5(1.25) --- 
 
Table 2 shows that the age group of <1 to 10 the highest 
number of samples i.e., 11 out of 20 gives a titer value of 
1:40. And in the age group of 11 to 20 the highest number of 
samples i.e., 9 out of 27 gives a titer value of 1:80, in the age 
group of 21 to 30 the highest number of samples i.e., 19 out 
of 45 gives a titre value of 1:80, in the age group of 31 to 40 
the highest number of samples i.e., 62 out of 135 gives a titer 
value of 1:80, in the age group of 41 to 50 the highest 
number of samples i.e., 51 out of 110 gives a titer value of 
1:80, in the age group of 51 to 60 the highest number of 
samples i.e., 38 out of 59 gives a titer value of 1:40, in the age 
group of 61 to 70 the highest number of samples i.e., 1 out of 
2 gives a titre value of 1:10 and 1:20 and in the age group of 
71 to 80 the highest number of samples i.e., 1 out of 1 gives a 
titer value of 1:10 and in the age group of > 80 the highest 
no. of samples is 1 out of 1 gives a titer value of 1:80.  The 
highest number of cases falls on the serum titer of 1:40 (159 
cases), followed by 1:80 (152), 1:20 (45), 1:10 (23), 1:160 
(16) and 1:320 (5). 
 
Table 3.  Serum titre value among patients against H 
S. 
No. 
Age Group 
(in years) 
Serum titre (n = 400) 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 
1 <1 to 10 (33) 4 7 13 9 -- -- -- 
2 11 to 20 (40) 9 11 8 11 1 -- -- 
3 21 to 30 (52) 1 4 28 18 1 -- -- 
4 31 to 40 (146) 5 12 45 78 5 1 -- 
5 41 to 50 (115) 6 8 19 74 7 1 -- 
6 51 to 60 (10) 1 3 2 3 1 -- -- 
7 61 to 70 (03) -- 1 1 1 -- -- -- 
8 71 to 80 (01) -- -- -- 1 -- -- -- 
9 > 80 (-) -- -- -- -- -- --- -- 
Total(n = 400) 26(6.5) 46(11.15) 116(29) 195(48.75) 15(3.75) 2(0.5)  
 
Table 3 shows that the age group of <1 to 10 the highest 
number of samples i.e., 13 out of 33 gives a titer value of 
1:40. And in the age group of 11 to 20 the highest number of 
samples i.e., 11 out of 40 gives a titre value of 1:20 and 1:80 
in the age group of 21 to 30 the highest number of samples 
i.e., 28 out of 52 gives a titer value of 1:40, in the age group 
of 31 to 40 the highest number of samples i.e., 78 out of 146 
gives a titer value of 1:80, in the age group of 41 to 50 the 
highest number of samples i.e., 74 out of 115 gives a titer 
value of 1:80, in the age group of 51 to 60 the highest 
number of samples i.e., 3 out of 10 gives a titre value of 1:20 
and 1 :80, in the age group of 61 to 70 the highest number of 
samples i.e., 1 out of 3 gives a titre value of 1:20,1:40  and 1 
:80 in the age group of 71 to 80 the highest number of 
samples i.e., 1 out of 1 gives a titer value of 1:80 . The highest 
number of cases falls on the serum titre of 1:80 (195 cases), 
followed by 1:40 (116), 1:20 (46), 1:10 (26) ,1:160 (15) and 
1:320(2). 
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Table 4. Serum titer value among Community controls against H 
S. 
No. 
Age Group 
(in years) 
Serum titre (n = 400) 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 
1 <1 to 10 (20) -- 2 8 10 -- -- -- 
2 11 to 20 (27) 3 11 7 5 1 -- -- 
3 21 to 30 (45) 5 3 27 9 1 -- -- 
4 31 to 40 (135) 10 22 35 60 7 1 -- 
5 41 to 50 (110) 6 18 32 47 6 1 -- 
6 51 to 60 (59) 7 14 21 16 1 -- -- 
7 61 to 70 (02) 1 -- 1 -- -- -- -- 
8 71 to 80 (01) -- -- -- 1 -- -- -- 
9 > 80 (01) -- -- 1 -- -- --- -- 
Total(n = 400) % 32(8) 70(17.5) 132(33) 148(37) 16(4) 2(0.5) --- 
 
Table 4 shows that the age group of <1 to 10 the highest 
number of samples i.e., 10 out of 20 gives a titer value of 
1:80. And in the age group of 11 to 20 the highest number of 
samples i.e., 11 out of 27 gives a titer value of 1:20, in the age 
group of 21 to 30 the highest number of samples i.e., 27 out 
of 45 gives a titre value of 1:40, in the age group of 31 to 40 
the highest number of samples i.e., 60 out of 135 gives a titer 
value of 1:80, in the age group of 41 to 50 the highest 
number of samples i.e., 47 out of 110 gives a titer value of 
1:80, in the age group of 51 to 60 the highest number of 
samples i.e., 21 out of 59 gives a titer value of 1:40, in the age 
group of 61 to 70 the highest number of samples i.e., 1 out of 
2  gives a titre value of 1:10 and 1:40 and in the age group of 
71 to 80 the highest number of samples i.e., 1 out of 1 gives a 
titer value of 1:80 and in the age group of >80 the highest no. 
of samples i,e 1 0ut of 1 gives a titer value of 1:40. The 
highest number of cases falls on the serum titer of 1:80 (148 
cases), followed by 1:40 (132), 1:20 (70), 1:10 (32), 1:160 
(16) and 1:320 (2). 
 
Table 5.  Serum titre value among patients against AH 
S. 
No. 
Age Group 
(in years) 
Serum titre (n = 400) 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 
1 <1 to 10 (33) 5 6 12 10 -- -- -- 
2 11 to 20 (40) 9 13 11 7 -- -- -- 
3 21 to 30 (52) 4 8 18 20 1 1 -- 
4 31 to 40 (146) 8 9 40 81 7 1 -- 
5 41 to 50 (115) 
6 
 
7 29 65 6 2 -- 
6 51 to 60 (10) 1 2 4 2 1 -- -- 
7 61 to 70 (03) 1 1 1 -- -- -- -- 
8 71 to 80 (01) -- -- -- 1 -- -- -- 
9 > 80 (-) -- -- -- -- -- --- -- 
Total (n = 400) 34(8.5) 46(11.5) 115(28.75) 186(46.5) 15(3.75) 4(1)  
 
Table 5 shows that the age group of <1 to 10 the highest 
number of samples i.e., 12 out of 33 gives a titer value of 
1:40. And in the age group of 11 to 20 the highest number of 
samples i.e., 13 out of 40 gives a titer value of 1:20, in the age 
group of 21 to 30 the highest number of samples i.e., 20 out 
of 52 gives a titre value of 1:80, in the age group of 31 to 40 
the highest number of samples i.e., 81 out of 146 gives a titer 
value of 1:80, in the age group of 41 to 50 the highest 
number of samples i.e., 65 out of 115 gives a titer value of 
1:80, in the age group of 51 to 60 the highest number of 
samples i.e., 4 out of 10 gives a titer value of 1:40, in the age 
group of 61 to 70 the highest number of samples i.e., 1 out of 
3 gives a titre value of 1:10,1:20 and 1:40 and in the age 
group of 71 to 80 the highest number of samples i.e., 1 out of 
1 gives a titer value of 1:80. The highest number of cases falls 
on the serum titre of 1:80 (186 cases), followed by 1:40 
(115), 1:20 (46), 1:10 (34), 1:10 (27) , 1:160 (15) and 1 
:320(4).
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Table 6. Serum titer value among Community controls against AH 
S. 
No. 
Age Group 
(in years) 
Serum titre (n = 400) 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 
1 <1 to 10 (20) 3 7 8 2 -- -- -- 
2 11 to 20 (27) 5 8 10 3 1 -- -- 
3 21 to 30 (45) 7 9 12 16 1 -- -- 
4 31 to 40 (135) 6 20 34 69 4 2 -- 
5 41 to 50 (110) 4 15 26 58 6 1 -- 
6 51 to 60 (59) 2 10 19 25 3 -- -- 
7 61 to 70 (02) -- -- 1 1 -- -- -- 
8 71 to 80 (01) -- -- -- 1 -- -- -- 
9 > 80 (01) -- -- 1 -- -- --- -- 
Total(n = 400) % 27(6.75) 69(17.25) 111(27.75) 175(43.75) 15(3.75) 3(0.75) --- 
 
Table 6 shows that the age group of <1 to 10 the highest 
number of samples i.e., 8 out of 20 gives a titer value of 1:40. 
And in the age group of 11 to 20 the highest number of 
samples i.e., 10 out of  27 gives a titer value of 1:40, in the 
age group of 21 to 30 the highest number of samples i.e., 16 
out of 45  gives a titre value of 1:80, in the age group of 31 to 
40 the highest number of samples i.e., 69 out of  135 gives a 
titer value of 1:80, in the age group of 41 to 50 the highest 
number of samples i.e., 58  out of 110 gives a titer value of 
1:80, in the age group of 51 to 60 the highest number of 
samples i.e., 25 out of 59  gives a titer value of 1:80, in the 
age group of 61 to 70 the highest number of samples i.e., 1 
out of  2 gives a titre value of 1:40 and 1: 80, in the age group 
of 71 to 80 the highest number of samples i.e., 1 out of 1 
gives a titer value of 1:80 and in the age group >80 the 
highest no. of samples is 1 out of 1 gives a titre value of 1:40. 
The highest number of cases falls on the serum titer of 1:80 
(175 cases), followed by 1:40 (111), 1:20 (69), 1:10 (27), 
1:160 (15) and 1:320 (3). 
 
Table 7.  Serum titre value among patients against BH 
S. 
No. 
Age Group 
(in years) 
Serum titre (n = 400) 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 
1 <1 to 10 (33) 10 18 4 1 -- -- -- 
2 11 to 20 (40) 14 16 6 4 -- -- -- 
3 21 to 30 (52) 8 15 16 12 1 -- -- 
4 31 to 40 (146) 20 56 35 32 3 -- -- 
5 41 to 50 (115) 16 44 29 22 2 2 -- 
6 51 to 60 (10) 4 2 2 1 1 -- -- 
7 61 to 70 (03) -- 1 1 1 -- -- -- 
8 71 to 80 (01) -- -- -- 1 -- -- -- 
9 > 80 (-) -- -- -- -- -- --- -- 
Total(n = 400) 72(18) 152(38) 93(23.25) 74(18.5) 7(1.75) 2(0.5)  
 
Table 7 shows that the age group of <1 to 10 the highest 
number of samples i.e., 18 out of 33 gives a titer value of 
1:20. And in the age group of 11 to 20 the highest number of 
samples i.e., 16 out of 40  gives a titer value of 1:20, in the 
age group of 21 to 30 the highest number of samples i.e., 16  
out of 52  gives a titre value of 1:40, in the age group of 31 to 
40 the highest number of samples i.e., 56  out of 146  gives a 
titer value of 1:20, in the age group of 41 to 50 the highest 
number of samples i.e., 44  out of 115 gives a titer value of 
1:20, in the age group of 51 to 60 the highest number of 
samples i.e., 4 out of 10 gives a titer value of 1:10, in the age 
group of 61 to 70 the highest number of samples i.e., 1 out of 
3 gives a titre value of 1:20, 1:40 and 1:80 and in the age 
group of 71 to 80 the highest number of samples i.e., 1 out of 
1 gives a titre value of 1:80. The highest number of cases 
falls on the serum titer of 1:20 (152 cases), followed by 1:40 
(93), 1:80 (74), 1:10 (72), 1:160 (7) and 1:320 (2). 
  
 
 
Wani et al                                                                                                                  Journal of Drug Delivery & Therapeutics. 2019; 9(3):194-199 
ISSN: 2250-1177                                                                                  [199]                                                                                 CODEN (USA): JDDTAO 
Table 8. Serum titer value among Community controls against BH 
S. 
No. 
Age Group 
(in years) 
Serum titre (n = 400) 
1:10 1:20 1:40 1:80 1:160 1:320 1:640 
1 <1 to 10 (20) 8 6 4 2 -- -- -- 
2 11 to 20 (27) 11 9 3 4 -- -- -- 
3 21 to 30 (45) 16 12 8 8 1 -- -- 
4 31 to 40 (135) 14 20 42 54 4 1 -- 
5 41 to 50 (110) 10 24 33 37 5 1 -- 
6 51 to 60 (59) 7 19 14 18 1 -- -- 
7 61 to 70 (02) -- -- 1 1 -- -- -- 
8 71 to 80 (01) -- -- -- 1 -- -- -- 
9 > 80 (01) -- -- 1 -- -- --- -- 
Total (n = 400) % 66(16.5) 90(22.5) 106(26.5) 125(31.25) 11(2.7) 2(0.5) --- 
 
Table 8 shows that the age group of <1 to 10 the highest 
number of samples i.e., 8 out of  20 gives a titer value of 1:10. 
And in the age group of 11 to 20 the highest number of 
samples i.e., 11 out of  27 gives a titer value of 1:10, in the 
age group of 21 to 30 the highest number of samples i.e., 16 
out of  45  gives a titre value of 1:10, in the age group of 31 to 
40 the highest number of samples i.e., 54  out of  135  gives a 
titer value of 1:80, in the age group of 41 to 50 the highest 
number of samples i.e., 37  out of  110  gives a titer value of 
1:80, in the age group of 51 to 60 the highest number of 
samples i.e., 19  out of 59  gives a titer value of 1:20, in the 
age group of 61 to 70 the highest number of samples i.e., 1 
out of  2 gives a titre value of 1:40  and  1:80, in the age 
group of 71 to 80 the highest number of samples i.e., 1 out of 
1 gives a titer value of 1:80 and in the age group >80 the 
highest no. of samples i,e 1 out of 1 gives a titre value of 1:40. 
The highest number of cases falls on the serum titer of 1:80 
(125 cases), followed by 1:40 (106), 1:20 (90), 1:10 (66), 
1:160 (11) and 1:320 (2). 
For the diagnosis of typhoid fever Widal test is the second 
most widely used after blood culture 13. A study showed a 
single Widal test titer against ‘O' antigen is 1:16014. Another 
study shows the widal baseline titer for anti-O is more or 
equal to 1:160 and for anti-H is more or equal to 1:320 and 
also it showed baseline titre for S. typhi is 1:160 for ‘O’ and 
1:160 for ‘H’13. A recent study showed the cut off value for 
anti-O titer is 1:80 15. Besides, our previous studies16,17 
concluded that out of 192 positive cases (IgM positive for 
typhidot), 189 were found positive for IgM and 3 were 
negative by ELISA method. Similarly, out of 40 positive cases 
(IgG positive for typhidot), 38 were found positive for IgM 
and 2 were negative by ELISA method. Thus the study found 
that the prevalence of typhoid was found higher in females 
than in males and children, and the other study concluded 
that in 263 normal individuals, C-reactive protein was below 
5 mg/dl. In 168 typhoid positive samples the C-reactive 
protein was found to be higher than 6 mg/dl whereas in 245 
typhoid positive samples the C-reactive protein was found to 
be less than 6 mg/dl. 
CONCLUSION 
The Widal baseline titer in this locality, in order to 
determine a threshold above which the antibody titer is 
considered as significant. The maximum percentage of 
antigens were detected of somatic antigen which was 
greater than flagellar antigen. There is a wider scope of 
community-based patients also in Kashmir province for the 
reason that of unawareness.     
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